Overview

Cerebrospinal Fluid Pharmacokinetics of Daptomycin

Status:
Terminated
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
This is a prospective pharmacokinetic study in patients having external ventricular drains with suspected external ventricular drain related bacterial meningitis. A single dose of daptomycin will be administered for the purposes of the study and PK samples will be obtained around this dosing.
Phase:
N/A
Details
Lead Sponsor:
University of Pittsburgh
Collaborator:
Cubist Pharmaceuticals LLC
Treatments:
Daptomycin